Rabeprazole 20 mg compared with esomeprazole 40 mg in the control of intragastric pH in healthy volunteers

被引：0
|
作者：
Baisley, K
Warrington, S
Tejura, B
Morocutti, A
Miller, N
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1289
引用
收藏
页码：A199 / A199
页数：1
相关论文
共 50 条
  • [1] Rabeprazole 20 mg compared with esomeprazole 40 mg in the control of intragastric pH in healthy volunteers
    Baisley, K
    Warrington, S
    Tejura, B
    Morocutti, A
    Miller, N
    GUT, 2002, 50 : A63 - A63
  • [2] Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers
    Wilder-Smith, CH
    Röhss, K
    Nilsson-Pieschl, C
    Junghard, O
    Nyman, L
    DIGESTION, 2003, 68 (04) : 184 - 188
  • [3] Early effects of tenatoprazole 40 mg and esomeprazole 40 mg on intragastric pH in Caucasian healthy volunteers
    Galmiche, JP
    des Varannes, SB
    Sacher-Huvelin, S
    Vavasseur, F
    Taccoen, A
    Fiorentini, P
    Homerin, M
    GASTROENTEROLOGY, 2004, 126 (04) : A334 - A334
  • [4] Effects of single doses of rabeprazole 20 mg and esomeprazole 40 mg on 24-h intragastric pH in healthy subjects
    Warrington, Steve
    Baisley, Kathy
    Dunn, Kate
    Boyce, Malcolm
    Morocutti, Anna
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (09) : 685 - 691
  • [5] Effects of single doses of rabeprazole 20 mg and esomeprazole 40 mg on 24-h intragastric pH in healthy subjects
    Steve Warrington
    Kathy Baisley
    Kate Dunn
    Malcolm Boyce
    Anna Morocutti
    European Journal of Clinical Pharmacology, 2006, 62 : 685 - 691
  • [6] A comparative study of the early effects of tenatoprazole 40 mg and esomeprazole 40 mg on intragastric pH in healthy volunteers
    Galmiche, JP
    Sacher-Huvelin, S
    des Varannes, SB
    Vavasseur, F
    Taccoen, A
    Fiorentini, P
    Homerin, M
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (05) : 575 - 582
  • [7] Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH and serum gastrin in healthy subjects
    Warrington, S
    Baisley, K
    Boyce, M
    Tejura, B
    Morocutti, A
    Miller, N
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (07) : 1301 - 1307
  • [8] Rabeprazole extended-release 50 mg compared with esomeprazole 40 mg and rabeprazole delayed release 20 mg
    Yuan, Y.
    Hunt, R. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (10) : 1177 - +
  • [9] Effect of intravenous esomeprazole 40 mg and pantoprazole 40 mg on intragastric pH in healthy subjects
    Piccoli, Franziska
    Ory, Gaeelle
    Hadengue, Antoine
    Beglinger, Christoph
    Degen, Lukas
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2007, 57 (10): : 654 - 658
  • [10] Comparison of the effects of esomeprazole 40 mg, rabeprazole 20 mg, lansoprazole 30 mg, and pantoprazole 40 mg on intragastric pH in extensive metabolizer patients with gastroesophageal reflux disease
    Celebi, Altay
    Aydin, Dincer
    Kocaman, Orhan
    Konduk, Bugra Tolga
    Senturk, Omer
    Hulagu, Sadetin
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2016, 27 (05): : 408 - 414
12345